Skip to content
No picture yet

Sandoz Capecitabine 150 mg – DIN 02421917

Sandoz Capecitabine is Capecitabine 150 mg (tablet), sold in Canada. It is used for breast cancer and colorectal cancer. It is supplied by Sandoz Canada Incorporated. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Capecitabine 150 mg

Brand
Sandoz Capecitabine
Strength
150 mg
Used for
Breast cancer and colorectal cancer
Form
Tablet
Manufacturer
Sandoz Canada Incorporated
Drug class
Nucleoside metabolic inhibitor
Sold in
Canada
DIN
02421917

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Capecitabine pills and guides

What is Capecitabine used for?

Capecitabine is used for breast cancer and colorectal cancer.

Medicine type
Nucleoside metabolic inhibitor
Official uses from the US prescribing label

Colorectal Cancer

Capecitabine tablets are indicated for the:

  • adjuvant treatment of patients with Stage III colon cancer as a single agent or as a component of a combination chemotherapy regimen.
  • perioperative treatment of adults with locally advanced rectal cancer as a component of chemoradiotherapy.
  • treatment of patients with unresectable or metastatic colorectal cancer as a single agent or as a component of a combination chemotherapy regimen.

Breast Cancer

Capecitabine tablets are indicated for the:

  • treatment of patients with advanced or metastatic breast cancer as a single agent if an anthracycline- or taxane-containing chemotherapy is not indicated.
  • treatment of patients with advanced or metastatic breast cancer in combination with docetaxel after disease progression on prior anthracycline-containing chemotherapy.

Gastric, Esophageal, or Gastroesophageal Junction Cancer

Capecitabine tablets are indicated for the:

  • treatment of adults with unresectable or metastatic gastric, esophageal, or gastroesophageal junction cancer as a component of a combination chemotherapy regimen.
  • treatment of adults with HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma who have not received prior treatment for metastatic disease as a component of a combination regimen.

Pancreatic Cancer

Capecitabine tablets are indicated for the adjuvant treatment of adults with pancreatic adenocarcinoma as a component of a combination chemotherapy regimen.

From the FDA-approved label on DailyMed (published Jul 22, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02421917.
  • It names Sandoz Capecitabine, Capecitabine 150 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Sandoz Capecitabine by Sandoz Canada Incorporated.

In Canada: prescription only.

Ingredients

Active: Capecitabine

Other Capecitabine pills